1-5 of 5
X. Feng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P2-10-07: A prospective clinical utility study of the impact of the 21-gene recurrence score (RS) assay in the treatment of estrogen receptor positive (ER+), HER2 negative (HER2-), 1-3 node positive (N+) breast cancer (BC)

Free
J Sun, D Fenton, S Baxter, A Chan, S Roberts, X Feng, C Lohrisch, K Gelmon, T Shenkier, S Chia
Journal: Cancer Research
Cancer Res (2018) 78 (4_Supplement): P2-10-07.
https://doi.org/10.1158/1538-7445.SABCS17-P2-10-07
Published: 15 February 2018
View articletitled, Abstract P2-10-07: A prospective clinical utility study of the impact of the 21-gene recurrence score (RS) assay in the treatment of estrogen receptor positive (ER+), HER2 negative (HER2-), 1-3 node positive (N+) breast cancer (BC)
Journal Articles

Abstract P2-05-33: Refining the prognostic value of Ki67 biomarker by ataxia telangiectasia mutated (ATM) status in a retrospective study of early stage hormone receptor positive breast cancer

Free
X Feng, H Li, E Kornarga, M Dean, S Lees-Miller, K Riabowol, A Magliocco, D Morris, P Watson, E Enwere, G Bebb, A Paterson
Journal: Cancer Research
Cancer Res (2017) 77 (4_Supplement): P2-05-33.
https://doi.org/10.1158/1538-7445.SABCS16-P2-05-33
Published: 15 February 2017
View articletitled, Abstract P2-05-33: Refining the prognostic value of Ki67 biomarker by ataxia telangiectasia mutated (ATM) status in a retrospective study of early stage hormone receptor positive breast cancer
Journal Articles

Abstract P6-09-20: Clinical utility of PgR with various cutpoints using 3 commercial assays relative to 15yr survival

Free
EN Kornaga, AHG Paterson, X Feng, DG Morris, AM Magliocco, AC Klimowicz
Journal: Cancer Research
Cancer Res (2017) 77 (4_Supplement): P6-09-20.
https://doi.org/10.1158/1538-7445.SABCS16-P6-09-20
Published: 15 February 2017
View articletitled, Abstract P6-09-20: Clinical utility of PgR with various cutpoints using 3 commercial assays relative to 15yr survival
Journal Articles

Abstract P5-07-07: Fluorescence quantitative image analysis of HER2 evaluation against current clinical HER2 assays in breast cancer testing

Free
EN Kornaga, X Feng, AC Klimowicz, ML Dean, N Guggisberg, DG Morris, AM Magliocco
Journal: Cancer Research
Cancer Res (2016) 76 (4_Supplement): P5-07-07.
https://doi.org/10.1158/1538-7445.SABCS15-P5-07-07
Published: 15 February 2016
View articletitled, Abstract P5-07-07: Fluorescence quantitative image analysis of HER2 evaluation against current clinical HER2 assays in breast cancer testing
Journal Articles

Fully Human Antibodies to MCAM/MUC18 Inhibit Tumor Growth and Metastasis of Human Melanoma

Available to Purchase
Lisa Mills, Carmen Tellez, Suyun Huang, Cheryl Baker, Marya McCarty, Larry Green, Jean M. Gudas, X. Feng, Menashe Bar-Eli
Journal: Cancer Research
Cancer Res (2002) 62 (17): 5106–5114.
Published: 01 September 2002
View articletitled, Fully Human Antibodies to MCAM/MUC18 Inhibit Tumor Growth and Metastasis of Human Melanoma
Open the PDF for Fully Human Antibodies to MCAM/MUC18 Inhibit Tumor Growth and Metastasis of Human Melanoma in another window